Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: kimberley who wrote (708067)	3/23/2020 12:54:02 PM
From: skinowski	Read Replies (3) \| Respond to of 793884

Yes, docs use it very widely, especially for very sick patients. It’s used legally - but off label, since these medications have never been approved to for this purpose. Informed consent is a complex concept - I’m not sure that a very sick, scared patient is truly capable of it. So, it’s complicated. Another issue, as D. Long noted, is that if manufacturers increase the production of these medications knowing that they’ll be used off label - they’re likely liable, as well. So, that’s a wrong incentive at a very wrong time. FDA must find a way to give them an emergency approval.